cardamonin and Cardiomyopathies

cardamonin has been researched along with Cardiomyopathies* in 1 studies

Other Studies

1 other study(ies) available for cardamonin and Cardiomyopathies

Article	Year
Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:3 Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Chalcones; Female; Heart; Inflammation; Lipopolysaccharides; Male; Mice; Myocardial Contraction; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; NF-kappa B p50 Subunit; Oxidative Stress; Signal Transduction	2021

Article

Year

Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism.

Acta pharmacologica Sinica, 2021, Volume: 42, Issue:3

Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Chalcones; Female; Heart; Inflammation; Lipopolysaccharides; Male; Mice; Myocardial Contraction; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; NF-kappa B p50 Subunit; Oxidative Stress; Signal Transduction

2021